$155M cancer pavilion expansion begins at Henry Ford Health

Detroit’s Henry Ford Health System has broken ground on a $155 million expansion of its cancer institute, to be named the Brigette Harris Cancer Pavilion.

The 187,000-square-foot facility is slated to open in 2019 across from the Henry Ford Hospital, with a skywalk bridge connecting the two buildings. The system said it will be a “destination center for ambulatory cancer treatment,” while also focusing on precision medicine, clinical trials and research.

“Precision medicine is the future of cancer treatment and the path to an eventual cure,” said Steven N. Kalkanis, MD, medical director of the Henry Ford Cancer Institute. “Being able to crack the molecular genetic code for each patient's individual cancer will allow us to zero in on the safest and most personalized treatment. When you combine that with access to Henry Ford's leading clinical trials and research programs, we really are building new hope for cancer patients worldwide.”

In addition to research programs, the center has promised many features focused on patients, including virtual tumor boards, telemedicine, integrated lab services and nurse navigators assigned to each patient.

The facility’s namesake, Brigette Harris, was a cancer patient at Henry Ford who died in 2016. Her husband Mort gave the system $40 million—labeled as the largest financial investment in a Detroit medical facility in the last 40 years—of which $20 million will be used for the new center.

“This is my life's work now – to partner with the people from Henry Ford to find a cure for pancreatic cancer,” Harris said in a statement. “I watched my wife suffer for 21 months with this disease and no one else should have to endure that.”

The center was designed by SmithGroupJJR, a Detroit firm which worked on other major hospital projects like the new George Washington University Hospital in Washington, D.C. and Kaiser Permanente’s 400-bed Los Angeles Medical Center.

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.